000			02249 a2200637 4500
005			20250515204118.0
264		0	_c20100201
008			201002s 0 0 ger d
022			_a1439-4413
024	7		_a10.1055/s-0029-1244830 _2doi
040			_aNLM _beng _cNLM
100	1		_aRosskopf, D
245	0	0	_a[Pharmacogenomics in routine medical care]. _h[electronic resource]
260			_bDeutsche medizinische Wochenschrift (1946) _cJan 2010
300			_a133-44; quiz 145-6 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article; Review
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAlleles
650	0	4	_aAnticholesteremic Agents _xpharmacokinetics
650	0	4	_aAnticoagulants _xpharmacokinetics
650	0	4	_aAntitussive Agents _xpharmacokinetics
650	0	4	_aAryl Hydrocarbon Hydroxylases _xgenetics
650	0	4	_aBiological Availability
650	0	4	_aBiotransformation _xgenetics
650	0	4	_aCodeine _xpharmacokinetics
650	0	4	_aCytochrome P-450 CYP2C9
650	0	4	_aCytochrome P-450 CYP2D6 _xgenetics
650	0	4	_aCytochrome P-450 CYP3A _xgenetics
650	0	4	_aCytochrome P-450 CYP3A Inhibitors
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHumans
650	0	4	_aInactivation, Metabolic _xgenetics
650	0	4	_aLiver-Specific Organic Anion Transporter 1
650	0	4	_aMale
650	0	4	_aMetabolic Clearance Rate _xgenetics
650	0	4	_aMethyltransferases _xdeficiency
650	0	4	_aMiddle Aged
650	0	4	_aNarcotics _xpharmacokinetics
650	0	4	_aOrganic Anion Transporters _xgenetics
650	0	4	_aPharmacogenetics
650	0	4	_aPhenotype
650	0	4	_aPhenprocoumon _xpharmacokinetics
650	0	4	_aPoint Mutation _xgenetics
650	0	4	_aPolymorphism, Genetic _xgenetics
650	0	4	_aPrecision Medicine
650	0	4	_aSimvastatin _xpharmacokinetics
650	0	4	_aWarfarin _xpharmacokinetics
700	1		_aMeyer zu Schwabedissen, H E
700	1		_aKroemer, H K
700	1		_aSiegmund, W
773	0		_tDeutsche medizinische Wochenschrift (1946) _gvol. 135 _gno. 4 _gp. 133-44; quiz 145-6
856	4	0	_uhttps://doi.org/10.1055/s-0029-1244830 _zAvailable from publisher's website
999			_c19477688 _d19477688